Ergül Yakup, Özyılmaz İsa, Güzeltaş Alper, Tola Hasan Tahsin
Department of Pediatric Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center and Research Hospital, İstanbul, Turkey.
Turk Kardiyol Dern Ars. 2015 Jan;43(1):82-5. doi: 10.5543/tkda.2015.65188.
Despite technological advancements in the field of pacemaker lead extraction, available data on pediatric patients is limited, and risk of failure and severe complications remains high. In this report, we present the case of a male patient who, at five months old, had been transvenously implanted with a single-chamber ventricular pacemaker due to complete atrioventricular block. At 7-year of age, the patient was referred to us with growth-related lead tension, severe tricuspid insufficiency, and weak battery. We extracted the lead using the Evolution System and replaced the unit with a dual-chamber pacemaker with a SelectSecure lead. This new system can be used for lead extraction even in low-weight pediatric patients with congenital heart disease. Using a thin, lumenless SelectSecure lead appears to reduce the risk of venous obstruction.
尽管起搏器导线拔除领域有技术进步，但关于儿科患者的现有数据有限，且失败风险和严重并发症风险仍然很高。在本报告中，我们介绍了一名男性患者的病例，该患者五个月大时因完全性房室传导阻滞经静脉植入了单腔心室起搏器。七岁时，该患者因与生长相关的导线张力、严重三尖瓣关闭不全和电池电量不足被转诊至我们处。我们使用Evolution系统拔除了导线，并用带有SelectSecure导线的双腔起搏器替换了该装置。这种新系统甚至可用于患有先天性心脏病的低体重儿科患者的导线拔除。使用细的、无腔的SelectSecure导线似乎可降低静脉阻塞的风险。
